Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NuestroBen: Shorter Benznidazole Regimens for Chagas Disease
NCT04897516Phase 3Recruiting
- Sponsor
- Laboratorio Elea Phoenix S.A.
- Start
- Jul 2021
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of benznidazole in Chagas disease, sponsored by Laboratorio Elea Phoenix S.A.. Started Jul 2021; status: recruiting.
02
Drugs
benznidazole
03
Conditions
Chagas disease
Beyond the preview
Go deeper on NCT04897516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04897516.